Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Martignoni

Showing results (181-190 of 209) with videos related to

Pageof 21
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 12, 2008
Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancerMark Hartel, Goutham Narla, Moritz N Wente, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Differential expression of metastasis-associated genes in papilla of vater and pancreatic cancer correlates with disease stageH Friess, X Z Guo, A A Tempia-Caliera, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 28, 2003
Parkinson's disease and reproductive life eventsE Martignoni, R E Nappi, A Citterio, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 16, 2021
A novel tissue inhibitor of metalloproteinases-1/liver/cachexia score predicts prognosis of gastrointestinal cancer patientsOlga Prokopchuk, Chris D Hermann, Benjamin Schoeps, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1991
Interobserver reliability between neurologists in training of Parkinson's disease rating scales. A multicenter studyG Geminiani, B M Cesana, F Tamma, et al.
Neurology|March 1, 1995
A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's diseaseG Pezzoli, E Martignoni, C Pacchetti, et al.
Clinical Neuropharmacology|May 14, 1998
A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's diseaseD J Brooks, R J Abbott, A J Lees, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1994
Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled studyG Pezzoli, E Martignoni, C Pacchetti, et al.
Molecular Metabolism|April 24, 2023
Diabetes increases mortality in patients with pancreatic and colorectal cancer by promoting cachexia and its associated inflammatory statusAlexandra Chovsepian, Olga Prokopchuk, Gabriela Petrova, et al.
The Journal of Biological Chemistry|May 9, 2025
Extent of N-glycosylation of the metalloproteinase inhibitor and cytokine TIMP-1 determines pancreatic cancer cell proliferation and survival via CD63Daniel Häußler, Damjan Manevski, Julian Frädrich, et al.
Pageof 21

Showing results (181-190 of 209) with videos related to

Sort By:
Pageof 21
European Journal of Cancer (Oxford, England : 1990)|August 12, 2008
Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancerMark Hartel, Goutham Narla, Moritz N Wente, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Differential expression of metastasis-associated genes in papilla of vater and pancreatic cancer correlates with disease stageH Friess, X Z Guo, A A Tempia-Caliera, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 28, 2003
Parkinson's disease and reproductive life eventsE Martignoni, R E Nappi, A Citterio, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 16, 2021
A novel tissue inhibitor of metalloproteinases-1/liver/cachexia score predicts prognosis of gastrointestinal cancer patientsOlga Prokopchuk, Chris D Hermann, Benjamin Schoeps, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1991
Interobserver reliability between neurologists in training of Parkinson's disease rating scales. A multicenter studyG Geminiani, B M Cesana, F Tamma, et al.
Neurology|March 1, 1995
A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's diseaseG Pezzoli, E Martignoni, C Pacchetti, et al.
Clinical Neuropharmacology|May 14, 1998
A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's diseaseD J Brooks, R J Abbott, A J Lees, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1994
Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled studyG Pezzoli, E Martignoni, C Pacchetti, et al.
Molecular Metabolism|April 24, 2023
Diabetes increases mortality in patients with pancreatic and colorectal cancer by promoting cachexia and its associated inflammatory statusAlexandra Chovsepian, Olga Prokopchuk, Gabriela Petrova, et al.
The Journal of Biological Chemistry|May 9, 2025
Extent of N-glycosylation of the metalloproteinase inhibitor and cytokine TIMP-1 determines pancreatic cancer cell proliferation and survival via CD63Daniel Häußler, Damjan Manevski, Julian Frädrich, et al.
Pageof 21